ArticleCurrent oncology (Toronto, Ont.)2024

A Locally Advanced NSCLC Patient Harboring a Rare KIF13A-RET Fusion Benefited from Pralsetinib: A Case Report.

Zenghao Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.